What Is Selank? The Russian Anxiety Peptide That Replaces Benzos

Watch the full video on Rumble: https://rumble.com/v7gdvlc-what-is-selank-the-russian-anxiety-peptide-that-replaces-benzos.html

There's a peptide that's been used in Russia as a prescription medication for over two decades, and it's on their official list of vital and essential medicines.

In clinical trials, it performed equivalent to benzodiazepines for anxiety reduction, but without the sedation, without the cognitive impairment, and without the dependence. That claim comes entirely out of Russian trial data, and I cannot point you to a study run in the West that replicates it, so hold it loosely while you read the rest of this.

It's called selank, and today I'm going to break down exactly what it is, how it works at the cellular level, what the clinical research actually says, and whether or not it makes sense for you.

This is not medical advice, and I suggest that before you put anything into your body, you consult with a licensed physician.

Alright, so before I can explain how selank works, you need to understand how your brain actually manages anxiety in the first place.

Because this is the system that selank is working on, and without this foundation, nothing else in the video is going to make sense.

You see, your brain has a neurotransmitter called GABA, which stands for Gamma-Aminobutyric Acid, and GABA is your brain's primary way of calming itself down.

You see, your brain is consistently firing these electrical signals between neurons, and when activity gets too high, that's when you feel anxious, overstimulated, or like your mind won't shut off.

GABA is what brings that activity back down, and when GABA binds to something called a GABA-A receptor on the surface of a neuron, it opens a channel that lets chloride ions flow in, and that makes the neuron less likely to fire. I am describing the textbook model of how this receptor behaves, and I have seen it repeated everywhere, but the specific chloride channel mechanics I just gave you are not something I can trace to a single study I have in hand.

Think of GABA as your brain's brake pedal. The system works when your brain speeds up for the things that need urgency, and then GABA brings it back down when the urgency passes.

But when GABA's signal is weak or disrupted, the brake pedal doesn't work as well, and your brain stays overactive, which is exactly what chronic anxiety feels like.

Xanax, Valium, Klonopin, all of them land on that same GABA-A receptor as benzodiazepines, and the common explanation is that they bind to a separate site and increase how often the chloride channel opens when GABA is already present, which is effectively slamming the brake pedal to the floor. The research hasn't been laid out for me in a form I can cite on that specific frequency mechanism, so take it as the standard pharmacology explanation rather than something I am sourcing for you.

Anxiety drops within minutes of taking one, which is exactly why these drugs became so widely prescribed in the first place.

Your brain is adaptive, though, and the explanation I have always heard is that when you amplify GABA signaling that aggressively and that often, the brain compensates by building fewer GABA receptors, a process called down-regulation, which then means you need more drug for the same effect. I have seen this pattern described for decades and I have watched people live it, but no study has shown it to me in a paper I can hand you here.

And that's tolerance.

A trial of patients sedated for colonoscopy laid out the sedation side with more precision than the rest of this picture. Adding midazolam to propofol produced measurable cognitive impairment at 30 and 60 minutes after the procedure that propofol alone did not produce, which tells you the benzodiazepine dampens cognition right alongside whatever anxiety relief it provides, rather than quieting anxiety on its own (Padmanabhan et al., 2009).

So the drug that solved the problem in week one is generating a second problem by month six.

Back in the 1990s, researchers at the Institute of Molecular Genetics at the Russian Academy of Scientists approach anxiety from a completely different direction. The origin story I just gave you is the one repeated in every writeup of this compound, and anecdotally it is consistent across sources, but there is no study in my hands documenting that development history.

They started with a naturally occurring peptide called Tuftsin.

And Tuftin is a four amino acid fragment of human immunoglobulin G, which is one of the proteins your immune system uses.

The account goes that the researchers extended that four amino acid sequence by three more to make it survive longer in the body and get into the brain, producing a seven amino acid peptide that kept Tuftsin's immune signaling behavior while also calming anxiety. I have seen that sequence story everywhere and I have never seen the primary paper behind it, so treat both the seven amino acid structure and the retained immune properties as reported rather than verified here.

Russia approved it for generalized anxiety disorder and neurasthenia, and it's been on their list of vital and essential medicines since 2011.

The mechanism is the part that really matters here, so here's how it works.

Research by Cassian and colleagues in 2017 showed that selenke enhances the axiolytic effect of GABA signaling, but uses a different binding mechanism than benzodiazepines.

And a 2016 study by Volkova confirmed that selenke changes the expression of 45 out of 84 genes involved and how GABA works in the brain.

Those 45 genes did not shift in a random direction. The pattern of change tracked what happens when GABA itself is given, and the changes registered within one hour, which puts the effect on a timescale fast enough to matter for how you actually feel.

Scientists call this positive allosteric modulation, meaning the compound sits somewhere other than the main binding site and changes how well the receptor responds to the GABA already there.

Picture your brain's GABA system as a speaker playing music, with the music already running before any drug enters the picture.

That's your natural GABA production.

Benzos are the volume knob cranked to the stop and held there. The music gets loud, the room fills, and it absolutely works, but hold the knob at the stop long enough and the cone tears.

That's tolerance and dependence.

Selank is closer to adjusting the speaker so the same music comes through cleanly. Volume rises a little, the hardware stays intact, and when you stop, it settles back to where it started.

Nothing in the system is being overridden, so there is nothing for the brain to push back against.

You're just making the system that's already there work a little bit better.

The first was published by Zazulia and colleagues in 2008, and they compared selenke to medazepam, which is a benzodiazepine commonly used in Russia for anxiety.

Anxiety reduction came out similar between the two arms, but selank also produced anti-fatigue and mild psychostimulant effects that medazepam did not, which is the opposite direction from what a sedating drug does to you.

The second trial was published by Medvedev and colleagues in 2014, and this one compared selenke to finazepam, which is another Russian benzodiazepine.

Comparable anxiety reduction again, and then the part worth sitting with: the anxiolytic effect held for up to one week after the final dose.

Most anxiolytics work only while the drug is still in your bloodstream, and the relief ends the moment you stop taking them. An effect that outlasts the compound by a week suggests the system itself shifted rather than the symptom being covered while drug was in the blood.

Against finazepam, selank showed no objectionable side effects and a positive impact on patient quality of life.

Every bit of human data on this peptide comes out of Russia. There are no published Western clinical trials, the sample sizes sit below what an FDA pathway would demand, and the long term safety picture is not settled by Western standards.

Beyond GABA, selank upregulates brain-derived neurotrophic factor, particularly in the hippocampus, which supports neuron survival and the formation of new connections. Chronic anxiety suppresses BDNF, and low BDNF makes anxiety worse, so a compound that calms the signaling and supports the repair side is working on both ends of that loop.

It also touches serotonin, dopamine and norepinephrine, which likely accounts for the mood and focus reports that go beyond the anxiety effect itself.

And it slows the enzymes that break down your enkephalins, your own pain and mood regulating peptides, so they stay active longer than they otherwise would.

Research: Padmanabhan U, Leslie K, Eer AS et al. Early cognitive impairment after sedation for colonoscopy appeared in Anesth Analg in 2009.